Novaliq Announces More than 50% Patients Enrolled in CyclASol(... - 28 April 2021 22:00

HEIDELBERG, Germany and CAMBRIDGE, Mass., April 28, 2021 /PRNewswire-AsiaNet/ -- - Topline results expected in 2nd half 2021; 475 out of a 834 target patients randomized in ESSENCE-2 - Enrollment for 12-month safety extension trial (ESSENCE-2 OLE) completed - Phase 2B/3 Trial ESSENCE-1 Published in Cornea: The Journal of Cor...

  ERT and Bioclinica Close Merger, Creating the Global Leader in... - 28 April 2021 21:59

PHILADELPHIA, April 28, 2021 /PRNewswire-AsiaNet/ -- ERT ( https://c212.net/c/link/?t=0&l=en&o=3132623-1&h=2992466112&u=https%3A%2F%2Fwww.ert.com%2F&a=ERT ), a global leader in clinical endpoint data solutions, today announced the close of its merger with Bioclinica ( https://c212.net/c/link/?t=0&l=...

  Albumedix extends research collaboration with Cobra Biologics ... - 28 April 2021 11:00

NOTTINGHAM and KEELE, United Kingdom, April 28, 2021 /PRNewswire-AsiaNet/ -- -- Collaboration investigates enhanced manufacturing of AAV and lentiviral vectors to improve quality and productivity for gene therapy and vaccine developers Albumedix Ltd. ('Albumedix') (https://albumedix.com/ ), an emerging leader in the e...

  HOYA Vision Care Releases Results of Three-Year MiYOSMART Spec... - 27 April 2021 23:33

BANGKOK, April 28, 2021 /PRNewswire-AsiaNet/ -- -- Strong evidence shows continued lens effectiveness in slowing myopia progression in children in third year HOYA Vision Care ( https://c212.net/c/link/?t=0&l=en&o=3142324-1&h=1257888903&u=https%3A%2F%2Fwww.hoyavision.com%2F&a=HOYA+...

  DiscGenics Completes Patient Enrollment in Japanese Clinical S... - 27 April 2021 11:23

SALT LAKE CITY and TOKYO, April 27, 2021 /PRNewswire-AsiaNet/ -- DiscGenics, Inc. ( https://www.discgenics.com/ ), a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, toda...

  Associates of Cape Cod, Inc. announces launch of PyroSmart Nex... - 24 April 2021 00:30

EAST FALMOUTH, Mass., April 24, 2021 /PRNewswire-AsiaNet/ -- Associates of Cape Cod, Inc. (ACC), a Seikagaku Group Company, announces the launch of a new, innovative, sustainable recombinant LAL reagent, PyroSmart NextGen(TM) for Bacterial Endotoxin Testing (BET). The new LAL reagent is sustainably produced...

  INOVIO Planning for ex-US Global Phase 3 Trial for INO-4800 - 23 April 2021 22:00

PLYMOUTH MEETING, Pa., April 23, 2021 /PRNewswire-AsiaNet/ -- -- Given universal eligibility and broad availability of COVID-19 vaccines in the U.S., DoD JPEO-CBRND has notified INOVIO that it will discontinue funding for the Phase 3 INO-4800 trial -- INOVIO adjusts INO-4800 clinical dev...

  Wuxi Strives to Build a World-class Biomedical Industry Chain - 22 April 2021 19:36

WUXI, China, April 22, 2021 /Xinhua-AsiaNet/-- From April 21 to 23, the 2021 Taihu Bay Future Healthcare Conference was held in Wuxi, China. More than 160 experts including Hejie, Fan Chunhai and many other academicians carried out forward-looking, authoritative, and predictive exchanges and d...

  RDIF and Minapharm agree to produce over 40 million doses of t... - 22 April 2021 18:00

MOSCOW, CAIRO and BERLIN, Apr. 22, 2021 /PRNewswire-AsiaNet/-- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), Egypt's Minapharm, the regional leader in recombinant DNA technology, and its Berlin-based subsidiary, ProBioGen AG, announce the agreement to produce over 40 million doses...

  Galderma launches new Multichannel Medical Education platform:... - 22 April 2021 17:00

LAUSANNE, Switzerland, April 22, 2021 /PRNewswire-AsiaNet/ -- - Launching in May, an inaugural four-part webinar series Unmasking Facial Skin & Dermatoses will feature expert presentations from world-renowned dermatologists - The program launches the Galderma Excellence in Multichannel Medical Educatio...